JurisdictionsTopicsUpdatesWorkflowsCompareChat with ExpertMarketplacePricing
🇫🇷
Medical — LegalEurope

France

France launched a medical cannabis pilot program in March 2021, initially enrolling 3,000 patients. The experiment was extended through 2025 and expanded to cover more conditions. A permanent framework is under legislative consideration following positive interim results.

Ask the Expert about France
Regulator
ANSM
Key Legislation
Decree No. 2020-1230
Year Legalized
2021 (pilot program)
Program Size
Approximately 3,000 patients in pilot...

Key Facts

  • The pilot program covers refractory epilepsy, neuropathic pain, cancer side effects, palliative care, and MS spasticity
  • ANSM oversees the experiment and evaluates outcomes for a permanent framework
  • Products include oils, capsules, and dried flower — smoking is prohibited
  • Cannabis must be prescribed by hospital specialists, not general practitioners
  • France has one of the highest rates of recreational cannabis use in Europe despite strict prohibition

Key Legislation

Decree No. 2020-1230 (October 2020)

Regulatory Body

ANSM (Agence nationale de sécurité du médicament)

Country Info
ISO Code
FR
Region
Europe
Tier
Tier 1 — Active Program
Status
Medical — Legal
Sources
ANSM — Cannabis MédicalLégifrance — Decree 2020-1230
Disclaimer: This information is for general reference only and does not constitute legal advice. Cannabis regulations change frequently. Always verify with official sources and local legal counsel before making compliance decisions.